GSK awarded Arrow declaration by UK High Court
Mr Justice Arnold shed some light on obviousness declaration criteria in the UK in his ruling that Vectura’s patents were not obvious but were insufficient
In a ruling that sheds light on the criteria for an obviousness declaration, the UK High Court has awarded Glaxo Smith Klein with an Arrow declaration after finding that the drug manufacturer had not infringed on another company’s patents.
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.